Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,148 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00508690 | Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic Antibiotics | completed | Phase 3 | 584 | Japan Multinational Trial OrganizationOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00147108 | MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas | terminated | Phase 3 | 102 | InSightecINDUSTRY | 2 | Sep 17, 2012 | clinicaltrials |
| NCT01009593 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 3 | 1,035 | AbbottINDUSTRY | 29 | Sep 10, 2012 | clinicaltrials |
| NCT00605267 | Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment | completed | Phase 3 | 197 | AstraZenecaINDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00344409 | A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients | completed | Phase 3 | 200 | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00471146 | Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | completed | Phase 3 | 630 | PfizerINDUSTRY | 24 | Jul 16, 2012 | clinicaltrials |
| NCT01411176 | Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy | completed | Phase 3 | 85 | Nihon Pharmaceutical Co., LtdINDUSTRY | 1 | Jun 29, 2012 | clinicaltrials |
| NCT01411189 | Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy | completed | Phase 3 | 33 | Nihon Pharmaceutical Co., LtdINDUSTRY | 1 | Jun 29, 2012 | clinicaltrials |
| NCT00373113 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine | terminated | Phase 3 | 482 | PfizerINDUSTRY | 23 | Jun 25, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT01167322 | Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas | completed | Phase 3 | 45 | NobelpharmaINDUSTRY | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00687843 | Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients(TMOG-GC01) | unknown | Phase 3 | 480 | Tokyo Metropolitan Oncology GroupOTHER | 1 | Mar 22, 2012 | clinicaltrials |
| NCT00143390 | Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer | completed | Phase 3 | 298 | PfizerINDUSTRY | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00519090 | Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)(ENEST) | terminated | Phase 3 | 6 | Novartis PharmaceuticalsINDUSTRY | 10 | Nov 7, 2011 | clinicaltrials |
| NCT00752115 | Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 120 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00150670 | Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer | completed | Phase 3 | 300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | completed | Phase 3 | 680 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | completed | Phase 3 | 1,300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152217 | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) | completed | Phase 3 | 1,000 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152230 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) | completed | Phase 3 | 900 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152243 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | completed | Phase 3 | 500 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00287768 | Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer | completed | Phase 3 | 628 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00639327 | Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | completed | Phase 2 / Phase 3 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT01214343 | Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC | unknown | Phase 3 | 190 | Ministry of Health, Labour and Welfare, JapanOTHER_GOV | 1 | Jun 15, 2011 | clinicaltrials |
| NCT01082510 | Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study) | unknown | Phase 3 | 288 | Urological Oncology Council of Northern TokyoOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00515450 | Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis | completed | Phase 3 | 46 | Benesis CorporationINDUSTRY | 1 | Jul 30, 2010 | clinicaltrials |
| NCT00209742 | Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer | unknown | Phase 3 | 340 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00723216 | Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery | completed | Phase 3 | 151 | SanofiINDUSTRY | 1 | Apr 5, 2010 | clinicaltrials |
| NCT00232661 | PROACT - Pre-Operative Arimidex Compared To Tamoxifen | completed | Phase 3 | 452 | AstraZenecaINDUSTRY | 10 | Feb 3, 2010 | clinicaltrials |
| NCT00280410 | Study Investigating the Effect of E7337 on Tumor Like Lesions in Computed Tomography (CT) of the Liver | completed | Phase 2 / Phase 3 | 192 | Eisai Inc.INDUSTRY | 1 | Jan 29, 2010 | clinicaltrials |
| NCT00628043 | Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients | completed | Phase 3 | 160 | Chugai PharmaceuticalINDUSTRY | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00195572 | Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer | completed | Phase 3 | 200 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 13, 2009 | clinicaltrials |
| NCT00195585 | Study Evaluating Isovorin in Colon Cancer | completed | Phase 3 | 650 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 13, 2009 | clinicaltrials |
| NCT00309101 | An Open Study for Steroid Resistant, Non-Thymectomized MG Patients | completed | Phase 3 | 11 | Astellas Pharma IncINDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00738478 | Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients | completed | Phase 3 | 180 | Wakayama Medical UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00149201 | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | completed | Phase 3 | 160 | Japan Clinical Oncology GroupOTHER | 1 | Feb 3, 2009 | clinicaltrials |
| NCT00149266 | Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502) | terminated | Phase 3 | 167 | Japan Clinical Oncology GroupOTHER | 1 | Feb 3, 2009 | clinicaltrials |
| NCT00503321 | Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma(eNCIT-Japan) | terminated | Phase 2 / Phase 3 | 13 | Eastern Network of Cancer Immunological Therapy, JapanOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00165633 | A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma | terminated | Phase 2 / Phase 3 | 540 | Eisai LimitedINDUSTRY | 1 | Dec 9, 2008 | clinicaltrials |
| NCT00131027 | High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) | unknown | Phase 3 | 240 | Japan Adult Leukemia Study GroupOTHER | 1 | Nov 14, 2008 | clinicaltrials |
| NCT00746161 | Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer | completed | Phase 3 | 44 | Wakayama Medical UniversityOTHER | 1 | Sep 4, 2008 | clinicaltrials |
| NCT00497107 | Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer(ICOG) | unknown | Phase 3 | 300 | Iwate Medical UniversityOTHER | 1 | Jul 31, 2008 | clinicaltrials |
| NCT00252707 | Iressa 2nd Line Phase III Study in Japan | completed | Phase 3 | 484 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00316745 | IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer | suspended | Phase 3 | 200 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00529412 | Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction | completed | Phase 3 | 150 | Nihon UniversityOTHER | 1 | Sep 14, 2007 | clinicaltrials |
| NCT00133302 | Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809) | terminated | Phase 3 | 450 | Japan Clinical Oncology GroupOTHER | 1 | Jan 18, 2007 | clinicaltrials |
| NCT00139971 | Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer | unknown | Phase 3 | 600 | West Japan Thoracic Oncology GroupOTHER | 1 | Jan 6, 2006 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials